Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2001-8-31
pubmed:abstractText
To compare the short-term efficacy and safety of low-dose fluticasone propionate with that of oral zafirlukast therapy for patients previously treated with beta-2-agonists alone, and to evaluate the potential therapeutic benefit of switching from zafirlukast to a low-dose inhaled corticosteroid.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0002-9343
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
111
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
195-202
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11530030-Administration, Inhalation, pubmed-meshheading:11530030-Adolescent, pubmed-meshheading:11530030-Adult, pubmed-meshheading:11530030-Aged, pubmed-meshheading:11530030-Androstadienes, pubmed-meshheading:11530030-Anti-Asthmatic Agents, pubmed-meshheading:11530030-Anti-Inflammatory Agents, pubmed-meshheading:11530030-Asthma, pubmed-meshheading:11530030-Child, pubmed-meshheading:11530030-Chronic Disease, pubmed-meshheading:11530030-Double-Blind Method, pubmed-meshheading:11530030-Drug Administration Schedule, pubmed-meshheading:11530030-Female, pubmed-meshheading:11530030-Humans, pubmed-meshheading:11530030-Lung, pubmed-meshheading:11530030-Male, pubmed-meshheading:11530030-Middle Aged, pubmed-meshheading:11530030-Respiratory Function Tests, pubmed-meshheading:11530030-Time Factors, pubmed-meshheading:11530030-Tosyl Compounds, pubmed-meshheading:11530030-Treatment Outcome
pubmed:year
2001
pubmed:articleTitle
A comparison of short-term treatment with inhaled fluticasone propionate and zafirlukast for patients with persistent asthma.
pubmed:affiliation
Asthma and Allergy Associates, P.C., Colorado Springs, Colorado 80907, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't